LiteBC Ltd.
Developer of a non-invasive, portable, point-of-care hematology analysis platform based on in-vivo spectral imaging and machine learning. The company aims to enable immediate, repeatable blood testing outside traditional laboratory settings and supports R&D, pre-clinical validation and clinical partnerships to advance a continuous, preventative and personalized medicine approach.
Industries
Nr. of Employees
small (1-50)
Products
Point-of-care hematology analyzer
A non-invasive, portable hematology analysis instrument that uses in-vivo spectral imaging and machine learning to produce immediate blood parameter readouts for use at point-of-care.
Point-of-care hematology analyzer
A non-invasive, portable hematology analysis instrument that uses in-vivo spectral imaging and machine learning to produce immediate blood parameter readouts for use at point-of-care.
Services
Design, implementation and optimization of deep learning and computer vision models for spectrally-resolved medical images; experimental design and performance evaluation.
Partnerships with pre-clinical study sites and clinical partners to support device validation, trial execution and data collection.
Design, implementation and optimization of deep learning and computer vision models for spectrally-resolved medical images; experimental design and performance evaluation.
Partnerships with pre-clinical study sites and clinical partners to support device validation, trial execution and data collection.
Expertise Areas
- Point-of-care diagnostics
- Hematology analysis
- Spectral / multispectral blood imaging
- Computer vision and deep learning for medical imaging
Key Technologies
- In-vivo spectral/multispectral imaging
- Spectroscopy-based microscopy
- Deep learning
- Computer vision
News & Updates
Proprietary Deep Spectral Vision technology described as patented and developed from over a decade of academic research.
References to pre-seed and seed investments and accelerator participation including support from academic and investment organizations.
Listed relationships with pre-clinical study sites and clinical partners for validation and testing.
Proprietary Deep Spectral Vision technology described as patented and developed from over a decade of academic research.
References to pre-seed and seed investments and accelerator participation including support from academic and investment organizations.
Listed relationships with pre-clinical study sites and clinical partners for validation and testing.